Index RUT
P/E -
EPS (ttm) -8.37
Insider Own 2.33%
Shs Outstand 61.15M
Perf Week 5.34%
Market Cap 5.81B
Forward P/E -
EPS next Y -2.82
Insider Trans -13.26%
Shs Float 59.80M
Perf Month -0.62%
Income -506.98M
PEG -
EPS next Q -1.67
Inst Own 105.00%
Short Float 8.61%
Perf Quarter 2.18%
Sales 249.38M
P/S 23.29
EPS this Y 33.10%
Inst Trans -2.86%
Short Ratio 6.32
Perf Half Y 89.99%
Book/sh 2.14
P/B 44.41
EPS next Y 49.63%
ROA -42.26%
Short Interest 5.15M
Perf Year 122.83%
Cash/sh 11.61
P/C 8.17
EPS next 5Y -
ROE -157.13%
52W Range 41.54 - 101.00
Perf YTD 2.84%
Dividend Est. -
P/FCF -
EPS past 5Y -9.19%
ROI -61.58%
52W High -6.08%
Beta 0.63
Dividend TTM -
Quick Ratio 3.66
Sales past 5Y 220.20%
Gross Margin 87.46%
52W Low 128.36%
ATR (14) 4.21
Dividend Ex-Date -
Current Ratio 3.76
EPS Y/Y TTM 10.38%
Oper. Margin -194.99%
RSI (14) 60.05
Volatility 4.38% 4.46%
Employees 655
Debt/Eq 5.93
Sales Y/Y TTM 22.22%
Profit Margin -203.30%
Recom 1.88
Target Price 97.38
Option/Short Yes / Yes
LT Debt/Eq 5.30
EPS Q/Q 31.25%
Payout -
Rel Volume 0.79
Prev Close 94.79
Sales Surprise 7.21%
EPS Surprise 10.77%
Sales Q/Q 85.55%
Earnings Feb 15 BMO
Avg Volume 814.66K
Price 94.86
SMA20 5.13%
SMA50 10.51%
SMA200 40.97%
Trades
Volume 646,740
Change 0.07%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-27-23 Upgrade
Oppenheimer
Perform → Outperform
$85
Aug-21-23 Reiterated
Needham
Buy
$65 → $66
Jul-31-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$55 → $82
Jun-05-23 Downgrade
SVB Securities
Market Perform → Underperform
$48 → $43
Jan-03-23 Upgrade
Wells Fargo
Underweight → Equal Weight
$41
Dec-14-22 Initiated
Needham
Buy
$60
Nov-02-22 Downgrade
Oppenheimer
Outperform → Perform
Sep-14-22 Initiated
Berenberg
Buy
$90
Jul-08-22 Initiated
Oppenheimer
Outperform
$80
Jun-27-22 Initiated
Wells Fargo
Underweight
$40
Jun-10-22 Downgrade
Citigroup
Neutral → Sell
$68 → $41
Jun-01-22 Upgrade
Jefferies
Hold → Buy
$88 → $78
Mar-01-22 Initiated
Citigroup
Neutral
$71
Feb-17-22 Downgrade
SVB Leerink
Outperform → Mkt Perform
$82
Jan-25-22 Upgrade
Stifel
Hold → Buy
$120 → $95
Nov-19-21 Resumed
Morgan Stanley
Equal-Weight
$111
Sep-30-21 Resumed
Stifel
Hold
$105
Jun-04-21 Resumed
Robert W. Baird
Outperform
$119
Mar-31-21 Initiated
Credit Suisse
Neutral
$100
Dec-03-20 Initiated
Stifel
Hold
$110
Show Previous Ratings
Mar-28-24 08:13AM
Mar-17-24 08:50AM
Mar-15-24 07:00PM
Mar-06-24 04:01PM
11:53AM
(Thomson Reuters StreetEvents)
08:00AM
Loading…
Feb-23-24 08:00AM
Feb-16-24 03:30PM
09:37AM
05:47AM
Feb-15-24 10:50PM
(Thomson Reuters StreetEvents) +14.02%
10:55AM
(Investor's Business Daily)
08:25AM
07:43AM
07:26AM
(Associated Press Finance)
07:00AM
(Investor's Business Daily)
07:00AM
Loading…
07:00AM
Feb-12-24 09:16AM
Feb-08-24 10:00AM
Feb-05-24 04:01PM
Feb-01-24 08:00AM
Jan-16-24 12:00PM
11:51AM
Jan-09-24 01:51PM
Jan-08-24 08:00AM
Jan-05-24 04:01PM
Dec-18-23 08:00AM
Dec-14-23 11:05AM
Dec-12-23 08:05AM
Dec-10-23 11:59AM
Dec-09-23 12:30PM
04:01PM
Loading…
Dec-04-23 04:01PM
Nov-28-23 08:00AM
Nov-14-23 05:05PM
Nov-13-23 04:29PM
Nov-10-23 08:00AM
Nov-04-23 03:02AM
Nov-03-23 04:01PM
Oct-31-23 09:55AM
09:40AM
03:48AM
Oct-30-23 03:46PM
Oct-28-23 01:49PM
Oct-27-23 10:01AM
07:27AM
Oct-26-23 11:42PM
(Thomson Reuters StreetEvents) +25.61%
05:47PM
09:30AM
08:52AM
08:15AM
07:09AM
(Associated Press Finance)
07:00AM
Oct-25-23 10:15AM
Oct-23-23 08:30AM
Oct-20-23 10:00AM
Oct-19-23 10:01AM
Oct-12-23 08:00AM
Oct-06-23 03:00AM
Oct-05-23 04:01PM
Sep-29-23 11:01PM
Sep-08-23 11:30AM
Sep-07-23 11:30AM
Sep-05-23 04:01PM
Sep-01-23 11:31AM
Aug-04-23 04:16PM
Aug-02-23 01:00PM
12:42PM
09:30AM
08:25AM
07:14AM
07:00AM
Jul-19-23 08:00AM
Jul-14-23 11:53AM
Jul-05-23 04:30PM
Jun-30-23 08:56AM
06:26AM
Jun-12-23 09:30AM
Jun-09-23 09:22AM
Jun-05-23 05:00PM
Jun-04-23 08:45AM
Jun-03-23 09:00AM
May-23-23 10:00AM
May-22-23 04:04PM
May-05-23 06:54AM
May-04-23 05:01PM
08:25AM
07:25AM
07:00AM
May-01-23 10:01AM
Apr-27-23 10:02AM
Apr-26-23 10:00AM
Apr-20-23 04:01PM
Apr-19-23 08:07AM
Apr-11-23 08:00AM
Apr-05-23 04:01PM
Mar-31-23 11:30AM
Mar-29-23 08:31AM
Mar-28-23 04:05PM
Mar-24-23 11:30AM
Mar-07-23 04:01PM
Feb-27-23 01:01PM
Blueprint Medicines Corp. is a precision therapy company, which engages in the invention of medicines for people with cancer and blood disorders. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy on October 14, 2008 and is headquartered in Cambridge, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Albers Jeffrey W. Director Mar 20 '24 Option Exercise 7.11 25,073 178,287 201,123 Mar 22 05:50 PM Albers Jeffrey W. Director Mar 20 '24 Sale 87.28 25,073 2,188,264 176,050 Mar 22 05:50 PM Landsittel Michael CHIEF FINANCIAL OFFICER Mar 15 '24 Option Exercise 36.05 5,000 180,250 61,020 Mar 19 05:11 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Mar 15 '24 Option Exercise 15.01 1,600 24,016 18,662 Mar 19 04:48 PM Landsittel Michael CHIEF FINANCIAL OFFICER Mar 15 '24 Sale 87.78 13,734 1,205,606 47,286 Mar 19 05:11 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Mar 15 '24 Sale 87.76 4,549 399,213 14,913 Mar 19 04:48 PM Lee Philina CHIEF COMMERCIAL OFFICER Mar 13 '24 Option Exercise 13.15 1,747 22,975 42,752 Mar 15 04:47 PM Lee Philina CHIEF COMMERCIAL OFFICER Mar 13 '24 Sale 90.40 8,023 725,277 34,729 Mar 15 04:47 PM Haviland Kate CHIEF EXECUTIVE OFFICER Mar 07 '24 Sale 90.69 12,464 1,130,360 153,177 Mar 11 06:27 PM Albers Jeffrey W. Director Mar 07 '24 Sale 90.69 11,033 1,000,583 165,017 Mar 26 09:11 PM Rossi Christina CHIEF OPERATING OFFICER Mar 07 '24 Sale 90.69 6,070 550,488 64,306 Mar 11 06:21 PM McCain Tracey L EVP AND CHIEF LEGAL OFFICER Mar 07 '24 Sale 90.69 5,194 471,044 60,498 Mar 11 06:18 PM Durso-Bumpus Debra CHIEF PEOPLE OFFICER Mar 07 '24 Sale 90.69 5,093 461,884 57,585 Mar 11 06:28 PM Landsittel Michael CHIEF FINANCIAL OFFICER Mar 07 '24 Sale 90.69 5,003 453,722 56,020 Mar 11 06:23 PM Namouni Fouad PRESIDENT, R & D Mar 07 '24 Sale 90.69 4,377 396,950 72,703 Mar 11 06:20 PM Hewes L. Becker CHIEF MEDICAL OFFICER Mar 07 '24 Sale 90.69 3,097 280,867 46,281 Mar 11 06:29 PM Lee Philina CHIEF COMMERCIAL OFFICER Mar 07 '24 Sale 90.69 2,934 266,084 41,005 Mar 11 06:26 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Mar 07 '24 Sale 90.69 2,521 228,629 33,853 Mar 11 06:24 PM Carter Percy H. CHIEF SCIENTIFIC OFFICER Mar 07 '24 Sale 90.69 2,286 207,317 48,331 Mar 11 06:19 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Mar 07 '24 Sale 90.69 1,462 132,589 17,862 Mar 11 06:15 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Mar 04 '24 Sale 93.65 621 58,157 36,374 Mar 06 10:41 AM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Feb 28 '24 Option Exercise 54.13 5,000 270,650 29,495 Mar 01 03:06 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Feb 28 '24 Sale 100.00 5,000 500,000 24,495 Mar 01 03:06 PM Albers Jeffrey W. Director Jan 25 '24 Option Exercise 7.13 25,000 178,150 201,050 Jan 29 06:13 PM Albers Jeffrey W. Director Jan 25 '24 Sale 81.91 25,000 2,047,800 176,050 Jan 29 06:13 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Dec 22 '23 Option Exercise 8.80 714 6,283 15,038 Dec 26 04:24 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Dec 22 '23 Sale 90.00 714 64,260 14,324 Dec 26 04:24 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Dec 15 '23 Option Exercise 1.87 3,654 6,833 16,411 Dec 19 04:05 PM Hurley Ariel PRINCIPAL ACCOUNTING OFFICER Dec 15 '23 Sale 84.35 3,914 330,146 14,324 Dec 19 04:05 PM Lee Philina CHIEF COMMERCIAL OFFICER Dec 13 '23 Option Exercise 1.87 261 488 31,439 Feb 14 06:54 PM Albers Jeffrey W. Director Dec 11 '23 Option Exercise 36.05 5,000 180,250 181,050 Dec 13 03:56 PM Albers Jeffrey W. Director Dec 11 '23 Sale 79.07 5,000 395,350 176,050 Dec 13 03:56 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Dec 07 '23 Option Exercise 54.13 5,000 270,650 29,495 Dec 11 05:11 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Dec 07 '23 Sale 75.00 5,000 375,000 24,495 Dec 11 05:11 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Dec 04 '23 Sale 71.43 600 42,858 24,495 Dec 06 08:45 PM Albers Jeffrey W. Director Nov 30 '23 Option Exercise 36.05 5,000 180,250 181,050 Dec 04 04:02 PM Albers Jeffrey W. Director Nov 30 '23 Sale 70.55 5,000 352,750 176,050 Dec 04 04:02 PM Albers Jeffrey W. Director Nov 24 '23 Option Exercise 1.87 15,000 28,050 191,050 Nov 28 04:05 PM Albers Jeffrey W. Director Nov 24 '23 Sale 67.51 15,000 1,012,690 176,050 Nov 28 04:05 PM Albers Jeffrey W. Director Nov 03 '23 Option Exercise 36.05 1,485 53,534 177,535 Nov 03 05:07 PM Albers Jeffrey W. Director Nov 03 '23 Sale 60.13 1,485 89,293 176,050 Nov 03 05:07 PM Albers Jeffrey W. Director Nov 02 '23 Option Exercise 36.05 4,634 167,056 180,684 Nov 03 05:07 PM Albers Jeffrey W. Director Nov 02 '23 Sale 60.37 4,634 279,749 176,050 Nov 03 05:07 PM Albers Jeffrey W. Director Nov 01 '23 Option Exercise 36.05 3,881 139,910 179,931 Nov 03 05:07 PM Albers Jeffrey W. Director Nov 01 '23 Sale 60.02 3,881 232,938 176,050 Nov 03 05:07 PM Murray Christopher K. CHIEF TECHNICAL OPERATIONS Oct 26 '23 Sale 56.40 600 33,840 25,095 Oct 30 02:01 PM Namouni Fouad PRESIDENT, R & D Oct 04 '23 Sale 48.06 3,769 181,138 62,080 Oct 05 10:47 AM Albers Jeffrey W. Director Sep 28 '23 Option Exercise 1.87 6,898 12,899 182,948 Sep 29 02:36 PM Albers Jeffrey W. Director Sep 28 '23 Sale 50.17 6,898 346,073 176,050 Sep 29 02:36 PM Albers Jeffrey W. Director Sep 27 '23 Option Exercise 1.87 18,102 33,851 194,152 Sep 29 02:36 PM Albers Jeffrey W. Director Sep 27 '23 Sale 49.61 18,102 897,957 176,050 Sep 29 02:36 PM Albers Jeffrey W. Director Aug 25 '23 Option Exercise 1.87 10,000 18,700 186,050 Aug 28 06:23 PM Albers Jeffrey W. Director Aug 25 '23 Sale 50.16 10,000 501,600 176,050 Aug 28 06:23 PM Albers Jeffrey W. Director Aug 24 '23 Option Exercise 1.87 15,000 28,050 191,050 Aug 28 06:23 PM Albers Jeffrey W. Director Aug 24 '23 Sale 49.57 15,000 743,550 176,050 Aug 28 06:23 PM Carter Percy H. CHIEF SCIENTIFIC OFFICER Jun 05 '23 Sale 52.06 2,307 120,102 38,117 Jun 07 07:52 PM Hewes L. Becker CHIEF MEDICAL OFFICER Jun 05 '23 Sale 52.05 1,404 73,078 36,878 Jun 07 07:48 PM
Index -
P/E 28.13
EPS (ttm) 0.98
Insider Own 0.00%
Shs Outstand 819.27M
Perf Week 2.49%
Market Cap 22.60B
Forward P/E 5.37
EPS next Y 5.14
Insider Trans -
Shs Float 819.27M
Perf Month 5.91%
Income 919.99M
PEG -
EPS next Q 0.96
Inst Own 4.54%
Short Float 0.68%
Perf Quarter -4.37%
Sales 68.26B
P/S 0.33
EPS this Y 298.44%
Inst Trans -2.81%
Short Ratio 3.68
Perf Half Y 12.99%
Book/sh 65.86
P/B 0.42
EPS next Y 18.28%
ROA 0.98%
Short Interest 5.56M
Perf Year -4.57%
Cash/sh 9.50
P/C 2.90
EPS next 5Y -12.61%
ROE 1.73%
52W Range 21.30 - 30.36
Perf YTD -2.85%
Dividend Est. 0.54 (1.97%)
P/FCF 7.46
EPS past 5Y -26.46%
ROI 1.48%
52W High -9.16%
Beta 1.93
Dividend TTM 0.44 (1.60%)
Quick Ratio 0.67
Sales past 5Y 0.37%
Gross Margin 6.94%
52W Low 29.48%
ATR (14) 0.48
Dividend Ex-Date Nov 13, 2023
Current Ratio 1.53
EPS Y/Y TTM -90.25%
Oper. Margin 3.43%
RSI (14) 60.60
Volatility 1.16% 1.33%
Employees 126756
Debt/Eq 0.20
Sales Y/Y TTM -15.92%
Profit Margin 1.35%
Recom 1.57
Target Price 34.18
Option/Short Yes / Yes
LT Debt/Eq 0.16
EPS Q/Q -
Payout 3.66%
Rel Volume 1.08
Prev Close 27.81
Sales Surprise -5.75%
EPS Surprise -58.70%
Sales Q/Q -15.97%
Earnings Feb 08 BMO
Avg Volume 1.51M
Price 27.58
SMA20 4.28%
SMA50 2.66%
SMA200 5.73%
Trades
Volume 1,635,442
Change -0.83%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-13-23 Upgrade
JP Morgan
Neutral → Overweight
Oct-18-23 Downgrade
BofA Securities
Buy → Neutral
Apr-03-23 Downgrade
Barclays
Overweight → Equal Weight
Mar-28-23 Upgrade
UBS
Sell → Buy
Mar-23-23 Upgrade
BofA Securities
Neutral → Buy
Dec-14-22 Downgrade
BofA Securities
Buy → Neutral
Oct-06-22 Downgrade
UBS
Buy → Neutral
Jun-22-22 Downgrade
JP Morgan
Overweight → Neutral
Jan-27-22 Downgrade
Goldman
Buy → Neutral
Oct-14-21 Upgrade
Credit Suisse
Neutral → Outperform
$34 → $42
Oct-14-21 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Jul-15-21 Initiated
Barclays
Overweight
Jan-25-21 Upgrade
JP Morgan
Neutral → Overweight
Jan-19-21 Downgrade
Credit Suisse
Outperform → Neutral
$24
Dec-15-20 Upgrade
Societe Generale
Hold → Buy
Oct-01-20 Upgrade
Kepler
Hold → Buy
Sep-17-20 Upgrade
BofA Securities
Neutral → Buy
Jul-15-20 Initiated
Goldman
Buy
Jun-23-20 Upgrade
Societe Generale
Sell → Hold
Apr-14-20 Downgrade
JP Morgan
Overweight → Neutral
Show Previous Ratings
Today 03:00AM
Mar-28-24 07:15AM
Mar-27-24 03:15PM
05:30AM
Mar-23-24 10:08AM
05:00AM
Loading…
Mar-19-24 05:00AM
Mar-18-24 01:00PM
Mar-14-24 01:52AM
Mar-13-24 10:15PM
01:03PM
11:43AM
Mar-12-24 05:00PM
Mar-11-24 01:30PM
Mar-08-24 04:54PM
Mar-04-24 11:53AM
12:00AM
Loading…
Mar-01-24 12:00AM
Feb-29-24 09:27AM
Feb-28-24 03:40PM
02:55PM
Feb-22-24 12:36PM
06:50AM
Feb-20-24 01:32PM
Feb-09-24 11:50AM
11:37AM
Feb-08-24 11:00AM
03:52AM
(The Wall Street Journal)
01:55AM
01:00AM
Feb-07-24 10:28AM
Feb-06-24 04:20PM
04:15PM
Loading…
Feb-05-24 04:15PM
09:16AM
Jan-17-24 11:52AM
Jan-16-24 04:15AM
Jan-14-24 10:32AM
Jan-11-24 11:18AM
07:04AM
Jan-09-24 10:59AM
Jan-04-24 06:36AM
Dec-22-23 02:00AM
Dec-21-23 12:00PM
11:24AM
09:20AM
08:44AM
Dec-19-23 07:00AM
04:06AM
Dec-18-23 02:25PM
Dec-14-23 08:20AM
Dec-11-23 12:10PM
Dec-08-23 02:40AM
Dec-06-23 10:35AM
Dec-05-23 04:30AM
Nov-30-23 11:49AM
Nov-21-23 10:51AM
12:00AM
Nov-20-23 12:58PM
Nov-17-23 11:04AM
09:50AM
12:05AM
Nov-16-23 10:40AM
09:53AM
Nov-15-23 02:00AM
Nov-10-23 08:51AM
Nov-09-23 02:00PM
12:23PM
09:30AM
03:59AM
01:55AM
01:32AM
01:00AM
Nov-06-23 08:10AM
05:00AM
01:31AM
Nov-03-23 07:02AM
Nov-02-23 05:08PM
Nov-01-23 12:50PM
Oct-30-23 10:45AM
07:50AM
Oct-29-23 04:43AM
Oct-28-23 11:38PM
05:01AM
(Associated Press Finance)
04:21AM
Oct-27-23 06:26AM
Oct-24-23 06:44AM
Oct-18-23 02:30AM
Oct-04-23 03:45AM
Oct-02-23 11:36AM
Sep-26-23 05:25PM
03:46PM
03:43PM
Sep-22-23 11:57AM
Sep-13-23 08:28AM
Aug-30-23 11:45AM
Aug-25-23 07:00AM
Aug-21-23 04:08PM
(American City Business Journals)
Aug-19-23 11:05AM
Aug-18-23 05:00PM
Aug-17-23 04:09PM
11:10AM
(American City Business Journals)
06:22AM
ArcelorMittal SA is a holding company, which engages in steelmaking and mining activities. It operates through the following business segments: NAFTA; Brazil; Europe; Africa and Commonwealth of Independent States (ACIS), Mining, and Others. The NAFTA segment consists of flat products such as slabs, hot-rolled coil, cold-rolled coil, coated steel, and plate. The Brazil segment covers wire rod, bar and rebars, billets, blooms, and wire drawing. The Europe segment offers hot-rolled coil, cold-rolled coil, coated products, tinplate, plate, and slab. The ACIS segment produces a combination of flat, long, and tubular products. The Mining segment focuses on steel operations. The company was founded by Lakshmi Niwas Mittal in 1976 and is headquartered in Luxembourg.
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite